The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility

Tai Kiuchi, Elena Ortiz-Zapater, James Monypenny, Daniel R Matthews, Lan K Nguyen, Jody Barbeau, Oana Coban, Katherine Lawler, Brian Burford, Daniel J Rolfe, Emanuele de Rinaldis, Dimitra Dafou, Michael A Simpson, Natalie Woodman, Sarah Pinder, Cheryl E Gillett, Viviane Devauges, Simon P Poland, Gilbert Fruhwirth, Pierfrancesco MarraYkelien L Boersma, Andreas Plückthun, William J Gullick, Yosef Yarden, George Santis, Martyn Winn, Boris N Kholodenko, Marisa L Martin-Fernandez, Peter Parker, Andrew Tutt, Simon M Ameer-Beg, Tony Ng

Research output: Contribution to journal › Article › peer-review

32 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology